WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below.
Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 by Intellectual Property Watch 1 Comment The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines.
“We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week’s Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed.
FIND Announces Four New Collaborations To Address AMR 31/01/2018 by Intellectual Property Watch Leave a Comment The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR).
The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 by Intellectual Property Watch 1 Comment Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably.
WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 by Catherine Saez, Intellectual Property Watch 5 Comments The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments.
Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes.
Facing Tense IP And Health Talks, WHO Board Erupts Into Dance (Video) 26/01/2018 by William New and Catherine Saez, Intellectual Property Watch Leave a Comment Member nations of the World Health Organization became accustomed in recent years to singing by the WHO director general, and sometimes crying, but under the new DG there seems to be a move toward the whole room getting up in the middle of serious negotiations and … dancing.
New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property.
WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 by Catherine Saez and William New, Intellectual Property Watch 1 Comment The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions.
